Dividend Daily Flow
  • Business
  • World News
  • Investing
  • Stock
World News

Biden DHS’s purchase of weapon linked to Havana Syndrome attacks leads House Republicans to demand answers

by admin January 16, 2026
January 16, 2026

The Biden administration purchased a pulsed energy weapon suspected of being the type that may have caused ‘Havana Syndrome’ which caused a series of mysterious ailments for U.S. diplomats and government workers in Cuba. 

The weapon was bought at the end of the Biden Administration and has since been tested by the Pentagon, Fox News has learned. House Republicans are demanding answers amid reports of the purchase of the device.

In a letter to Homeland Security Kristi Noem, House Committee on Homeland Security Chairman Andrew Garbarino, R-N.Y., is asking for information on the procurement process for the weapon, its costs and the findings associated with its year-long testing related to Havana Syndrome, officially known as Anomalous Health Incidents (AHI). 

‘The device in question is described as capable of producing pulsed radio waves and containing Russian components, though it is supposedly not entirely Russian in origin,’ the letter states. ‘Following HSI’s successful acquisition of the device, it was reportedly transferred to DoW, which spent more than a year testing the device and its capabilities.’

Some U.S. intelligence agencies have said a foreign adversary could be behind the mysterious ailment. 

Fox News Digital previously reported that Adam, a former government employee whose identity Fox News agreed to protect, is considered to be ‘Patient Zero.’

He was first attacked in December 2016 while living in Havana on assignment. During his time on the Caribbean island, Adam experienced multiple attacks and described pressure to the brain that led to vertigo, tinnitus and cognitive impairment.

‘While assessments from the Intelligence Community (IC) do not conclusively identify the factors causing AHIs or any foreign actor responsible, an assessment from the Office of the Director of National Intelligence (ODNI) presented a majority view concluding that it was ‘very unlikely’ that a foreign actor ‘used a novel weapon or prototype device to harm even a subset of the U.S. Government personnel,’ with five out of seven agencies agreeing with that assessment,’ Garbarino wrote in his letter. 

‘However, two agencies dissented from the majority view and assessed that there was a chance that foreign actors may have developed some sort of ‘novel weapon or prototype device’ that could have harmed U.S. personnel,’ he added. 

However, the Office of the Director of National Intelligence (ODNI) released the report and held a background call with reporters on Friday explaining that new reporting ‘led two components to shift their assessments about whether a foreign actor has a capability that could cause biological effects consistent with some of the symptoms reported as possible AHIs.’

‘This shift consequently led two IC components to subtly change their overall judgment about whether a foreign actor might have played a role in a small number of events,’ the agency said. 

Fox News’ Liz Friden contributed to this report. 

This post appeared first on FOX NEWS

previous post
Venezuelan opposition leader María Corina Machado presents Nobel medal to Trump despite institute ban
next post
Former Ukrainian PM accused of bribing politicians with US dollars to weaken Zelenskyy’s government

You may also like

Trump touts 5-0 sweep by endorsed candidates in...

March 12, 2026

DAVID MARCUS: Sen Thune has no idea how...

March 12, 2026

Cornyn reverses on filibuster stance to push Trump’s...

March 12, 2026

US destroys 16 Iranian mine boats as Strait...

March 12, 2026

House GOP urges Trump to choke off Iran...

March 12, 2026

US strike on key Iran oil hub would...

March 11, 2026

DOJ blasts ‘partisan’ DC Bar complaint against senior...

March 11, 2026

Putin caught executing enormous ‘semi-dark’ ship-to-ship oil transfer...

March 11, 2026

Rubio designates Afghanistan as ‘state sponsor of wrongful...

March 11, 2026

Speaker Johnson touts Trump’s agenda as crucial blueprint...

March 11, 2026

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Business News

    • United Airlines says it will boot passengers who refuse to use headphones on planes

      March 7, 2026
    • DOJ takes Live Nation-Ticketmaster to court for antitrust trial

      March 5, 2026
    • L.A. County sues Roblox, alleges platform makes it easy for adults to target children

      February 22, 2026
    • Warner Bros. Discovery reopens talks with Paramount

      February 19, 2026
    • CFTC chief sides with prediction markets over state regulators in a high-stakes court case

      February 19, 2026
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: dividenddailyflow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 dividenddailyflow.com | All Rights Reserved

    Dividend Daily Flow
    • Business
    • World News
    • Investing
    • Stock